Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa – KINDLE Study

•The Middle East and Africa (MEA) subset of global KINDLE study revealed substantial diversity in treatment patterns for stage III NSCLC.•Disparity in treatment decisions and heterogeneous nature of stage III disease leads to poor survival outcomes.•Better access to newer therapies and quality care is crucial in improving patient outcomes in MEA.•Unmet needs to adapt to therapeutic improvements, optimum timing, and an apt treatment sequencing with an multi-disciplinary team (MDT) approach in stage III non-small cell lung cancer (NSCLC).